The lawyers tend to see this phenomenon through the catastrophic frame of lost IPa billion-dollar brand name up in smoke
However, comprehensive medical history and individualized risk-benefit assessment remain essential components of prescribing decisions
Glucagon-like peptide-1 (GLP-1) receptors, which the medication activates to reduce hunger and slow stomach emptying, become less stimulated
Some observed notable changes in their body composition and waist circumference, while others experienced gastrointestinal adverse events such as nausea, diarrhea, constipation, or headaches
In an email to Drug Discovery & Development , Nicholas Chimicles, lead counsel for the plaintiffs, declined to comment further on the litigation but said the firm was aware of the recent New York Times profile of MEDVi
Over time, your body can adapt to this medication, leading to a diminished effect on appetite suppression